|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 65.68 USD | +0.26% |
|
-1.28% | +10.52% |
| Market Cap | 12.71B 10.95B 10.37B 9.4B 17.64B 1,215B 17.73B 123B 47.37B 618B 47.75B 46.7B 1,953B | P/E 2026 * |
22.5x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 14.79B 12.74B 12.07B 10.94B 20.52B 1,413B 20.62B 143B 55.11B 719B 55.55B 54.33B 2,272B | EV / Sales 2026 * |
3.78x | EV / Sales 2027 * | 3.14x |
| Free-Float |
99.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BMRN | Delayed | |
CBOE
| BMRN | Real-time | |
|
Tradegate
| BM8 | Real-time | |
|
London S.E.
| 0HNC | Delayed | |
|
Wiener Boerse
| BMRN | End-of-day quote | |
|
Mexican S.E.
| BMRN * | End-of-day quote | |
|
Berne S.E.
| BM8 | End-of-day quote | |
|
Boerse Muenchen
| BM8 | Real-time | |
|
Deutsche Boerse AG
| BM8 | Delayed | |
|
Börse Stuttgart
| BM8 | Delayed | |
|
Borsa Italiana
| 1BMRN | End-of-day quote |
Last Transcript : BioMarin Pharmaceutical Inc.
| 1 day | +0.26% | ||
| 1 week | -1.28% | ||
| Current month | +0.69% | ||
| 1 month | -6.49% | ||
| 3 months | +17.39% | ||
| 6 months | +11.19% | ||
| Current year | +10.52% |
| 1 week | 63.57 |  | 66.26 |
| 1 month | 63.57 | | 69.62 |
| Current year | 49.26 | | 70.98 |
| 1 year | 49.26 | | 70.98 |
| 3 years | 49.26 | | 99.56 |
| 5 years | 49.26 | | 117.77 |
| 10 years | 49.26 | | 131.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 57 | 2023-11-30 |
Brian Mueller
DFI | Director of Finance/CFO | 52 | 2020-01-28 |
Arpit Davé
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Willard Dere
BRD | Director/Board Member | 72 | 2016-07-17 |
Robert Hombach
BRD | Director/Board Member | 60 | 2017-09-28 |
| Director/Board Member | 69 | 2019-07-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/26 | Sell | General Counsel | -17,557 | 0.0091% | ||
| 6/2/26 | Free | Director | 7,490 | 0.0039% | ||
| 6/2/26 | Free | Director | 7,490 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.26% | -1.28% | +21.43% | -28.66% | 12.71B | |
| -1.48% | -5.59% | +39.55% | -6.16% | 78.04B | |
| +5.38% | -1.09% | +512.38% | +36.80% | 57.48B | |
| -1.42% | -4.24% | -19.59% | -38.20% | 57.4B | |
| -0.56% | -2.21% | -11.34% | +27.29% | 48.81B | |
| +1.93% | -2.37% | -0.87% | +149.45% | 45.5B | |
| +0.80% | -1.67% | +49.90% | -15.98% | 32.08B | |
| -1.47% | -4.17% | +46.17% | +89.12% | 24.62B | |
| -0.85% | -8.64% | -4.39% | +161.31% | 20.77B | |
| -0.09% | -3.61% | +62.49% | +98.37% | 15.75B | |
| Average | +0.25% | -3.61% | +69.57% | +47.34% | 39.31B | |
| Weighted average by Cap. | +0.37% | -3.63% | +88.32% | +35.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.91B 3.37B 3.19B 2.89B 5.42B 373B 5.45B 37.88B 14.57B 190B 14.68B 14.36B 600B | 4.47B 3.85B 3.64B 3.3B 6.2B 427B 6.23B 43.27B 16.64B 217B 16.77B 16.4B 686B |
| Net income | 570M 491M 465M 421M 791M 54.45B 795M 5.52B 2.12B 27.7B 2.14B 2.09B 87.53B | 917M 790M 748M 678M 1.27B 87.58B 1.28B 8.88B 3.42B 44.56B 3.44B 3.37B 141B |
| Net Debt | 2.08B 1.79B 1.69B 1.54B 2.88B 198B 2.9B 20.12B 7.74B 101B 7.8B 7.63B 319B | 1.32B 1.13B 1.07B 973M 1.83B 126B 1.83B 12.75B 4.9B 63.95B 4.94B 4.83B 202B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$65.68 | +0.26% | 1,604,794 |
| 26-09-10 | US$65.51 | +1.71% | 2,202,737 |
| 26-09-09 | US$64.41 | -0.34% | 1,949,632 |
| 26-09-08 | US$64.63 | -2.86% | 1,457,634 |
| 26-09-04 | US$66.53 | +0.15% | 2,299,208 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BMRN Stock
Select your edition
All financial news and data tailored to specific country editions
